VIP-152
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VIP-152, covering 2025-04-08 to 2025-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies [Phase 1, Phase 2]